Company Filing History:
1 out of 38 
1 out of 1 Years Active: 2024
Title: Rubén Artero Allepuz: Innovator in Oligonucleotide Research
Introduction
Rubén Artero Allepuz is a notable inventor based in Valencia, Spain. He has made significant contributions to the field of biotechnology, particularly in the development of oligonucleotide-based therapies. His innovative work focuses on the modulation of microRNAs, which play crucial roles in various biological processes.
Latest Patents
Rubén Artero Allepuz holds a patent for "Oligonucleotides conjugated to oleic acid and uses thereof." This invention provides oligonucleotide and/or oligonucleotide analogue molecules that act as antagonists of specific human microRNAs, namely hsa-miR-23b-3p and hsa-miR-218-5p. The oligonucleotides are designed to comprise a mixture of phosphorothioate and phosphodiester linkages, conjugated to oleic acid molecules. By inhibiting these microRNAs, the invention aims to increase the endogenous levels of the corresponding proteins MBNL1 and/or MBNL2. Furthermore, the patent outlines compositions that include these oligonucleotides and their potential applications for the treatment and prevention of diseases in subjects in need.
Career Highlights
Throughout his career, Rubén has been associated with esteemed institutions such as Universitat De Valencia and Arthex Biotech S.L. His work in these organizations has allowed him to advance his research and contribute to the scientific community.
Collaborations
Rubén has collaborated with talented individuals, including Nerea Moreno Cervera and Irene González Martínez. These partnerships have enriched his research endeavors and fostered innovation in the field.
Conclusion
Rubén Artero Allepuz is a pioneering inventor whose work on oligonucleotides has the potential to impact therapeutic strategies significantly. His contributions to biotechnology exemplify the importance of innovation in addressing complex medical challenges.